Department of Hepatology, Institute of Liver & Biliary Sciences (ILBS), New Delhi, 110070, India.
Department of Biostatistics, Institute of Liver & Biliary Sciences, New Delhi, India.
Dig Dis Sci. 2024 Oct;69(10):3942-3951. doi: 10.1007/s10620-024-08634-z. Epub 2024 Sep 16.
Liver and splenic stiffness measurements (LSM and SSM) are useful to predict varices and clinical decompensation in cirrhosis. SSM values are highly variable and overlapping and no guidelines exists on what constitutes normal SSM, that might limit interpretation of results.
Consecutive subjects with LSM < 6 kPa and reliable SSM (FibroScan630 Expert device with spleen-dedicated module) and no vascular liver disease were analysed for significant correlations of SSM values with age, sex, BMI, portal and splenic vein diameter, splenic diameter, liver fat and diabetes. Based on timeline of SSM, subjects were randomly assigned in 70:30 ratio into derivation [n = 502] and validation subset [n = 214].
Of 7200 subjects with simultaneous reliable LSM and SSM, 715 fulfilled the selection criteria (mean age: 43.8 ± 12.8 years, 67.2% male, mean BMI-26.4 ± 4.5 kg/m). The mean SSM was 22.6 ± 5.8 kPa (c10-c90 percentile range: 15.2-31.3 kPa) and followed the normal distribution curve. In the derivation subset, mean SSM for males was higher than female (23.06 ± 6.2 vs. 21.78 ± 5.93 kPa; p = 0.028). SSM value correlated with LSM (r = 0.454, p = 0.001). Mean SSM in subjects with LSM 3-4, 4.1-5 and 5.1-6 kPa were 21.7 ± 5.8, 22.27 ± 5.67 and 23.76 ± 5.88 kPa (p value = 0.001). There was no difference in SSM based on age, BMI, diabetes and liver fat on ultrasound. Above results hold true for subjects in validation subset.
SSM range in subjects with normal LSM and no vascular liver disease using spleen-dedicated module varies from 15.2 to 31.3 kPa, values being higher in male and not affected by Age, BMI, spleen size, liver fat and diabetes. Our results may serve as reference point in evaluation of SSM in compensated advanced liver disease patients.
肝脏和脾脏硬度测量(LSM 和 SSM)可用于预测肝硬化患者的静脉曲张和临床失代偿。SSM 值变化较大且重叠,目前尚无关于什么构成正常 SSM 的指南,这可能限制了结果的解释。
连续纳入 LSM<6kPa 和可靠 SSM(FibroScan630Expert 设备和脾脏专用模块)且无血管性肝病的患者,分析 SSM 值与年龄、性别、BMI、门静脉和脾静脉直径、脾脏直径、肝脏脂肪和糖尿病的显著相关性。根据 SSM 的时间轴,将患者随机按 70:30 的比例分为推导组(n=502)和验证组(n=214)。
在 7200 例同时具有可靠 LSM 和 SSM 的患者中,有 715 例符合入选标准(平均年龄:43.8±12.8 岁,67.2%为男性,平均 BMI-26.4±4.5kg/m2)。平均 SSM 为 22.6±5.8kPa(c10-c90 百分位范围:15.2-31.3kPa),呈正态分布曲线。在推导组中,男性 SSM 高于女性(23.06±6.2 与 21.78±5.93kPa;p=0.028)。SSM 值与 LSM 相关(r=0.454,p=0.001)。LSM 为 3-4kPa、4.1-5kPa 和 5.1-6kPa 的患者 SSM 平均值分别为 21.7±5.8kPa、22.27±5.67kPa 和 23.76±5.88kPa(p 值均<0.001)。SSM 不受年龄、BMI、糖尿病和超声下肝脏脂肪的影响。验证组患者也有相同结果。
使用脾脏专用模块的正常 LSM 和无血管性肝病患者的 SSM 范围为 15.2-31.3kPa,男性患者的 SSM 值较高,不受年龄、BMI、脾脏大小、肝脏脂肪和糖尿病的影响。我们的结果可为评估代偿性晚期肝病患者的 SSM 提供参考。